IDentaIDTA 46 EBIT per Share is $0.06 as of Mar. 2026. GuruFocus rates IDTA with a GF Score™ of 46/100 and a GF Value™ of $0.35 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 168 Medical Diagnostics & Research companies, IDenta ranks worse than 50.6% on this metric.
IDenta's EBIT per Share for the
three
months ended in Mar. 2026 was $0.01.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.06.
During the past 12 months, the average EBIT per Share Growth Rate of IDenta was 1014.30% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 13.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for IDenta's EBIT per Share or its related term are showing as below:
IDTA'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 2.6 Med: 9.85 Max: 13
Current: 13
During the past 8 years, the highest 3-Year average EBIT per Share Growth Rate of IDenta was 13.00% per year. The lowest was 2.60% per year. And the median was 9.85% per year.
IDTA's 3-Year EBIT Growth Rate is ranked worse than 50.6% of 168
companies
in the Medical Diagnostics & Research industry
Industry Median: 13.1
vs IDTA: 13.00
IDenta's EBIT for the
three
months ended in Mar. 2026 was $0.03 Mil.
IDenta (OTCPK:IDTA) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
IDenta EBIT per Share Related Terms
IDenta EBIT per Share Historical Data
* Premium members only.
The historical data trend for IDenta's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.06
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IDenta (IDTA) has a EBIT per Share of $0.06 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on IDenta and its competitors. According to the industry distribution chart, IDenta ranks #85 out of 168 companies in the Medical Diagnostics & Research industry, placing it in the top 50.6%.
Is IDenta's EBIT per Share too high?
IDenta's current EBIT per Share is $0.06. The Medical Diagnostics & Research industry median EBIT per Share is 13.10. IDenta's value of $0.06 is 99.5% below this industry median. Based on the distribution chart, IDenta ranks #85 out of 168 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, IDenta has a GF Score™ of 46/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IDenta's EBIT per Share compare to NSTM and PRPH?
According to the Medical Diagnostics & Research industry distribution chart, IDenta ranks #85 out of 168 companies for EBIT per Share. This places IDenta in the lower half of its industry. The industry median EBIT per Share is 13.10. IDenta's value of $0.06 is 99.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Diagnostics & Research company?
The median EBIT per Share among Medical Diagnostics & Research companies is 13.10, based on 168 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IDenta's current EBIT per Share of $0.06 is 99.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on IDenta and its competitors. For the Medical Diagnostics & Research industry, the median EBIT per Share is 13.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IDenta's current EBIT per Share is $0.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDenta stock overvalued right now?
Based on GuruFocus' analysis, IDenta (IDTA) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.35, compared to a current price of $0.28 — trading 21.4% below its estimated fair value. The current EBIT per Share is $0.06 and 99.5% below the Medical Diagnostics & Research industry median of 13.10. IDenta's overall GF Score™ is 46/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For IDenta (IDTA), the current EBIT per Share is $0.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IDenta (IDTA) Overvalued in 2026?
Based on GuruFocus' analysis, IDenta stock appears to be undervalued.
The current stock price of $0.28 is trading 21.4% below its estimated GF Value™ of $0.35.
GuruFocus considers IDenta to be Modestly Undervalued.
Key valuation signals for IDTA:
EBIT per Share: $0.06
GF Value™: $0.35 vs. price of $0.28 (21.4% below fair value)
Industry Position: 99.5% below the Medical Diagnostics & Research median (#85 of 168)
No single metric tells the full story. See the IDTA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IDenta Corp is a detection and forensic science company. The firm, through its subsidiary, is engaged in the business of developing products to test for the presence of illegal drugs and explosives for law enforcement agencies, ports and border crossings, shipping hubs, and other organizations. Its product portfolio includes Drug testing kits, Explosive testing kits, Forensic products, Urine drug testing and others. The company currently sells its products to law enforcement organizations in the following countries: Indonesia, Argentina, Poland, France, USA, Spain, India, the United Kingdom, Ghana, Nigeria, Australia, Russia, Israel, Canada, Germany, Italy, and Portugal. The company also sells to retail markets in the United States, Italy, and South Africa.
46GF Score
Get the complete analysis for IDTA
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IDTA has been successfully added to your 
